like us on facebook connect with us on linkedin follow us on twitter September 18, 2019

Welcome to the Reimbursement Bulletin

MSHO Confidentiality Statement

This Bulletin will be published semi-monthly.  As always, any comments, suggestions, stories or questions can be sent to billing@msho.org

Section Header

Important Oncology Related News

~ Important Reimbursement Alert Related to Billing of Drug Waste to Medicare Plus Blue
~ Cigna Creates New Program to Pay for High-Price Gene Therapies
~ ASTRO Comments To The Centers For Medicare And Medicaid Services Regarding Their Proposed Radiation Oncology Alternative Payment Model
~ COA Formal Comments to CMS on Proposed Radiation Oncology Alternative Payment Model (RO Model)

Details >

A Message From Your E-bulletin Sponsor

AstraZeneca

~ The AstraZeneca Access 360TM program provides personal support to help streamline access and reimbursement for select AstraZeneca medicines. Take a look at the REDESIGNED MyAccess360.com!

Details >
Section Header Section Header

MSHO Featured Corporate Sponsor Assistance Program

Incyte

~ Oncology-related products: Jakafi® (ruxolitinib) tablets

Details >
Section Header

WPS Oncology Related LCD Updates

September 2019

Including;
~ Revised Erythropoiesis Stimulating Agents (ESAs) - Effective August 29, 2019

Details >

WPS Recent Oncology Related News

Part A, Part B and Part A/B News

Includes articles that may be of interest to oncology released in the past 2 weeks
~ Also, Medicare Hot Links to Fee Schedules and 2020 Proposed and 2019 Final CMS Rules

Details >

Join WPS for a Teleconference, Webinar or Seminar!

Check out these upcoming training events....

Including....
~ Teleconferences: Observation - Clinical coverage and Billing Criteria 9/26
~ Webinars: Appeals Webinar Series 9/18, 9/25,10/2 - Medicare Secondary Payer Series 9/25
~ PLUS many more educational opportunities including E & M training opportunities!

Details >
Section Header

Michigan RAC Information

Region 1 - Performant Recovery, Inc.

Latest Issues Under Review That May be Significant to Oncology...
~ Complex Coding Validation and Subsequent Hospital and Discharge Day Posted in April, 2019 - no oncology related new issues posted since.

Details >

Recent RAC Monitor Articles

This edition includes an articles on......

~ CMS Tightens Rules Governing Reporting on Affiliated Parties
~ Medicare Audits: Deference to the Agency or the Judges?

Details >

CMS-Medicare

Recent Oncology Related Articles

~ MIPS Targeted Review Request Deadline September 30
~ Local Coverage Determination Meetings
~ Advance Care Planning — Revised
~ Medicare Billing: CMS Form CMS-1500 and the 837 Professional — Revised
~ Medicare Secondary Payer— Revised
~ Radiation Oncology Listening Session: Audio Recording and Transcript
~ Medicare Secondary Payer Provisions Web-Based Training Course — Revised
~ Quality Payment Program for Merit-based Incentive Payment System (MIPS) APMs in 2019 Web-Based Training Course — Revised
~ Quality Payment Program: 2019 Resources
~ Recent LearnResource & MedLearn Matters Articles

Details >
Section Header

Blues 201 - AIM Specialty Health Webinars

MSHO Members - Don't miss this opportunity 9/24 and 9/26!

Details >

BCBSM/BCN

Recent Oncology Related News

~ BCBSM Recoupment Error with E499
~ Blue Cross beginning recovery of Medicare Plus Blue no-cost drug claims paid in error
~ NASCO conducting payment recovery for Trinity Health
~ NASCO starting payment recovery for Woodbridge Holdings Inc.
~ Sign up for September provider webinars
~ Starting in January, AllianceRx Walgreens Prime is BCN's specialty pharmacy provider
~ New Edits for BCN HMO and BCN Advantage claims reporting V, W, X or Y diagnosis codes
~ Are you missing out on your value based reimbursement incentive payments?
~ Effective November 1, Inflectra® is the preferred infliximab product for adult Blue Cross' PPO (commercial) members
~ Medicare Part B medical specialty drug prior authorization list is changing in October
~ We're adding drugs to prior authorization, site of care programs for PPO members, effective October 2019

Details >

BCBSM/BCN

Publications

~ The Record
~ BCN Provider News
~ Blues Brief for Oncology Providers

Details >

Medicare Plus Blue

September Monthly Status Report

Many updates/corrections. Listed below is a sampling of what you will find...
~ 835 Recoupment Isn't Reflected on the Voucher
~ J0881 and J0885 claims are denying incorrectly (System corrected on May 10 with reprocessing of claims complete by 9/30)
~ Providers are getting false eligibility information for processing eviCore claims
~ Evicore denying A9513 Radiation and Oncology claims in error and more...

Details >
Section Header

Payer Issue Tracking Page

Last Updated 9/17/19

Review the reported payer reimbursement issues MSHO is currently addressing including WPS, BCBSM, Medicare Plus Blue, Meridian. This update includes information on the resolution of the MDS Retacrit issue with WPS Medicare.

Details >

Medicaid

Recent Oncology Related Issues and News

Pending Medicaid Issues being Addressed by MSHO:
~ None at this time.

Additional Medicaid Updates:
~ MSA Bulletin Updates
~ Biller "B" Aware Notices

Details >

Newsletters of Interest

~ Aetna OfficeLink Updates
~ Cigna
~ HAP
~ Humana YourPractice
~ UHC Network Bulletin
~ UHC Medical Policy Update

Details >

Managed Care Committee Reimbursement TIDBITS

Featuring this month: HAP

Tidbits regarding;
~ Genetic Testing
~ NDC Coding Requirements
~ Appeal Limitations

Details >

UnitedHealthcare Updates

Updates to Requirements for Specialty Medical Injectable Drugs

You’ll need to use a new process to request a prior authorization once the existing authorization expires or if you change the therapy

Details >

Priority Health Update

~ Priority Health Website - Recent News  - Modifier 26 
~ Step therapy added for select Medicare Part B drugs effective Oct. 1, 2019

Details >
Section Header

Recent Oncology Related Drug News

~ New Packaging for Keytruda
~ Here’s What We Know About How Drugs Are Priced — And What We Don’t
~ UnitedHealthcare Will Prefer Amgen's Anticancer Biosimilars Beginning in October

Details >
Section Header Section Header

ASK MSHO

September 2019, Frequently Asked Questions

Topic:
~ IV vs Push administration coding
~ Drug Waste
~ Use of JW modifier for waste less than the HCPCS unit
~ New vs Established Patient Billing
~ Nurse Practitioner Education Billing
~ Chemo Drugs with both a professional and a facility charge

Details >